KFDA to promote earlier commercialization of biodrugs

Published: 2002-12-02 06:59:00

Updated: 2002-12-02 06:59:00

The Korea Food and Drug Administration (KFDA) unveiled a plan to undertaken some research projects covering the license of biodrugs, safety of cell- and tissue-engineered drugs, and safety assessment of gene-related drugs so as to strengthen the competitiveness of biotechnology products and shorten the preparatory period of preclinical data.

The KFDA also plans to draft a guideline concernin...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.